Terms: = Thyroid cancer AND BTK, AGMX1, 695, ENSG00000010671, XLA, IMD1, RP1-164F3_2, MGC126262, BPK, ATK, MGC126261, Q06187, AT, PSCTK1 AND Staging
691 results:
1. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
Sang Y; Min R; Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
[TBL] [Abstract] [Full Text] [Related]
2. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
3. DNA Methylation-Regulated HOXC8's Role in HER2-Positive Breast cancer Function and its Contribution to Herceptin Resistance.
Xie X; Tang S; Yu Z
Discov Med; 2024 Mar; 36(182):559-570. PubMed ID: 38531796
[TBL] [Abstract] [Full Text] [Related]
4. Dosimetry during iodine-131 therapy - a technical point of view from a single centre's own experience.
Chalewska W; Cegla P; Moczulska A; Strzemecka E; Sackiewicz A; Dedecjus M
Nucl Med Rev Cent East Eur; 2024; 27(0):1-5. PubMed ID: 38529769
[TBL] [Abstract] [Full Text] [Related]
5. The crosstalk between benign thyroid disease and breast cancer: A single center study.
Zheng Y; Tang H; Wu J; Guan D; Mo Q; Zheng Q
Medicine (Baltimore); 2024 Mar; 103(10):e37298. PubMed ID: 38457535
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
7. First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
Soll D; Bischoff P; Frisch A; Jensen M; Karadeniz Z; Mogl MT; Horst D; Penzkofer T; Spranger J; Keilholz U; Mai K
BMC Endocr Disord; 2024 Feb; 24(1):25. PubMed ID: 38383419
[TBL] [Abstract] [Full Text] [Related]
8. Impact of prophylactic central lymph node dissection on the complications and recurrence rates in papillary thyroid carcinoma-An AFCE (French-speaking Association of Endocrine Surgery) multicentre study based on the EUROCRINE® national data.
Chereau N; Christou N; Caiazzo R; Le Fouler A; Lifante JC; Maillard L; Mirallie E; Pattou F; Bouviez N; Santucci N; Brunaud L; Menegaux F
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1993. PubMed ID: 38351532
[TBL] [Abstract] [Full Text] [Related]
9. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
10. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary thyroid Carcinoma.
Lai HF; Hang JF; Kuo PC; Kuo CS; Yao SF; Chen JY; Lee CH
Ann Surg Oncol; 2024 May; 31(5):3495-3501. PubMed ID: 38300401
[TBL] [Abstract] [Full Text] [Related]
11. The American thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology.
Croce L; Teliti M; Chytiris S; Sparano C; Coperchini F; Villani L; Calì B; Petrone L; Magri F; Trimboli P; Rotondi M
Eur J Endocrinol; 2024 Feb; 190(2):165-172. PubMed ID: 38298148
[TBL] [Abstract] [Full Text] [Related]
12. Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated thyroid cancer in the West of Scotland: A Retrospective Analysis.
Graham K; Tough F; Belikova H; Wotherspoon I; Colville D; Reed N
Endocr Pract; 2024 Apr; 30(4):327-332. PubMed ID: 38184240
[TBL] [Abstract] [Full Text] [Related]
13. Effects of short- and long-term TSH suppression on lumbar bone mineral density in both genders using PET/CT.
Einspieler H; Walter C; Hacker M; Karanikas G; Tamandl D
Sci Rep; 2023 Dec; 13(1):22640. PubMed ID: 38114753
[TBL] [Abstract] [Full Text] [Related]
14. The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary thyroid cancer.
Gild ML; Kumar S; Fuchs TL; Glover A; Sidhu S; Sywak M; Tsang V; Gill AJ; Robinson BG; Schembri G; Clifton-Bligh RJ; Hoang J
Endocr Pract; 2024 Mar; 30(3):218-224. PubMed ID: 38103829
[TBL] [Abstract] [Full Text] [Related]
15. Social Vulnerability Association with thyroid cancer Disparities in the United States.
Fei-Zhang DJ; Verma R; Arimoto R; Lawrence AS; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
Thyroid; 2024 Feb; 34(2):225-233. PubMed ID: 38069566
[No Abstract] [Full Text] [Related]
16. Association of ABCG2 Polymorphisms on Triple Negative Breast cancer (TNBC) Susceptibility Risk.
Hao Ing Y; Md Salleh MS; Yahya MM; Ankathil R; Abdul Aziz AA
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3891-3897. PubMed ID: 38019248
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological characteristics and prognosis of medullary thyroid microcarcinoma: a tumor with a similar prognosis to macrocarcinoma.
Wu X; Li B; Zheng C
Eur J Med Res; 2023 Nov; 28(1):546. PubMed ID: 38017592
[TBL] [Abstract] [Full Text] [Related]
18. Impact of Additional Preoperative Computed Tomography Imaging on staging, Surgery, and Postsurgical Survival in Patients With Papillary thyroid Carcinoma.
Jeong SY; Chung SR; Baek JH; Choi YJ; Kim S; Sung TY; Song DE; Kim TY; Lee JH
Korean J Radiol; 2023 Dec; 24(12):1284-1292. PubMed ID: 38016686
[TBL] [Abstract] [Full Text] [Related]
19. [Standardized and individualized treatment improves survival rate and quality of life for advanced thyroid cancer].
Fang JG
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3152-3154. PubMed ID: 37879867
[TBL] [Abstract] [Full Text] [Related]
20. How do
Mukhtar N; Alhamoudi K; Alswailem M; Alhindi H; Murugan AK; Alghamdi B; Alzahrani AS
Front Endocrinol (Lausanne); 2023; 14():1270796. PubMed ID: 37859987
[TBL] [Abstract] [Full Text] [Related]
[Next]
